|Bid||0.00 x 1000|
|Ask||0.00 x 900|
|Day's range||48.35 - 48.87|
|52-week range||36.91 - 58.10|
|Beta (5Y monthly)||0.39|
|PE ratio (TTM)||13.53|
|Forward dividend & yield||1.90 (3.96%)|
|Ex-dividend date||25 May 2023|
|1y target est||N/A|
Sanofi (SNY) closed the most recent trading day at $48.56, moving +1.17% from the previous trading session.
Sanofi (SNY) and Regeneron's Dupixent becomes the first and only targeted medicine approved to treat severe atopic dermatitis in kids as young as six months old in Europe.
Yahoo Finance’s Anjalee Khemlani joins the Live show to report that Sanofi has become the latest major drug company to slash insulin prices, capping the cost at $35.